[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371037-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371037-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multi-cohort-validation-based-on-coagulation-related-genes-for-predicting-prognosis-of-esophageal-squamous-cell-carcinoma-research-article","Multi-cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma - Research Article","","Hypercoagulable states are common in malignancies and are closely linked to tumor progression and immune microenvironment remodeling. Coagulation-related gene (CRG) signatures have shown prognostic and immunotherapy value across cancers, but their role in esophageal squamous cell carcinoma (ESCC) remains unclear. This study builds a CRGs signature, validates it across multiple RNA transcriptome cohorts, and evaluates its associations with immune infiltration, TMB, TIDE, and immunotherapy response. A six-gene model offers independent prognostic power while implicating SULT1B1 as a tumor-suppressive factor in vitro.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multi-cohort-validation-based-on-coagulation-related-genes-for-predicting-prognosis-of-esophageal-squamous-cell-carcinoma-research-article/371037/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multi-cohort-validation-based-on-coagulation-related-genes-for-predicting-prognosis-of-esophageal-squamous-cell-carcinoma-research-article/371037.png","ImageObject",300,407,{"name":42,"@type":43},"PakDamar76","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What clinical problem does the study address in ESCC?","Question",{"text":63,"@type":64},"The study targets the lack of investigation into how coagulation-related gene signatures can predict ESCC prognosis and immunotherapy responsiveness.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the CRGs signature developed and validated?",{"text":68,"@type":64},"Patients were stratified using consensus clustering, differential and univariate Cox analyses were applied to construct the signature, and multiple RNA transcriptome cohorts were used for validation.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings link the signature to tumor immunity and immunotherapy response?",{"text":72,"@type":64},"High-risk ESCC showed higher immune infiltration, lower tumor mutation burden (TMB), higher TIDE, and a lower proportion of immunotherapy response compared with low-risk cases.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371037,1790217130,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Original Research PUBLISHED 26 November 2025 DOI 10.3389/fimmu.2025.1662599  \nOPEN ACCESS  \nEDITED BY  \nAnand Rotte,  \nArcellx Inc, United States  \nREVIEWED BY  \nHao Zhang,  \nShanghai Jiao Tong University, China Jiaqi Zhang,  \nThe First Afﬁliated Hospital of Dalian Medical University, China  \n*CORRESPONDENCE  \nZhongquan Yi  \n[yizhongquan@163.com](yizhongquan@163.com)[ ](yizhongquan@163.com)JianXiang Song  \n[jxsongycsy@163.com](jxsongycsy@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 09 July 2025  \nREVISED 05 November 2025  \nACCEPTED 12 November 2025  \nPUBLISHED 26 November 2025  \nCITATION  \nWang R, Zhang W, Li X, Wang H, Ji Y, Zhao J, Song J and Yi Z (2025) Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.  \nFront. Immunol. 16:1662599 .  \ndoi: 10.3389/fimmu.2025.1662599  \nCOPYRIGHT  \n© 2025 Wang, Zhang, Li, Wang, Ji, Zhao, Song and Yi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMulti−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma  \nRui Wang 1,2†, Weisong Zhang 1†, Xia Li 3†, Hao Wang 1, Yanan Ji 4, Jing Zhao 4, JianXiang Song 1* and Zhongquan Yi 4*  \n1 Department of Cardiothoracic Surgery, Afﬁliated Hospital 6 of Nantong University, Yancheng Third People’s Hospital, Yancheng, China, 2 Department of Cardiovascular Surgery, The First Afﬁliated Hospital of Nanjing Medical University, Nanjing, China, 3 Department of General Medicine, Afﬁliated Hospital 6 of Nantong University, Yancheng Third People ’s Hospital, Yancheng, China, 4 Department of Central Laboratory, Afﬁliated Hospital 6 of Nantong University, Yancheng Third People’s Hospital, Yancheng, China  \nObjective: In malignant tumors, a hypercoagulable state is frequently observed and is intricately intertwined with cancer development and the remodeling of the immune microenvironment. Recently, the coagulation-related genes (CRGs) signature has emerged as highly signiﬁcant for the prognosis and immunotherapy of patients with various cancers. Nevertheless, their application in esophageal squamous cell carcinoma (ESCC) remains uninvestigated. Here, our objective is to explore the role of the CRGs signature in forecasting prognosis and predicting patient’s response to immunotherapy.  \nMethods: According to the prognostic CRGs, consensus clustering was utilized to stratify ESCC patients in the GSE53625 cohort into two subgroups. Subsequently, difference analysis and univariate cox analysis were conducted on the two subgroups, and a CRGs signature was constructed by leveraging these genes. Next, multiple RNA transcriptome cohorts were utilized to validate the signature. Moreover, functional enrichment, tumor mutation burden (TMB), tumor inﬁltration, immune function, and immunotherapy response of this signature were investigated.  \nResults: A CRGs signature composed of six genes (PTX3, CILP, CFHR4, SULT1B1, IL5RA, and FAM151A) was constructed. This signature serves as an independent and reliable prognostic factor. Additionally, when compared with the 32 prognostic signatures previously reported, the CRGs signature exhibited superior performance in the ESCC prognostic cohorts. Additionally, we found that high-risk ESCC exhibited higher immune inﬁltration, lower TMB, higher TIDE, and a lower proportion of immunotherapy response. In vitro experiments have shown that the gene SULT1B1, which exhibits the highest accuracy in predicting tumor status, signiﬁcantly inhibited the proliferation and metastasis.  \nFrontie","cbCairMzToGLuYdo","https://ap.wps.com/l/cbCairMzToGLuYdo","pdf",8782267,"English","# Objective\n# Methods\n# Results\n# Conclusions\n# Keywords\n# 1 Introduction","[{\"question\":\"What clinical problem does the study address in ESCC?\",\"answer\":\"The study targets the lack of investigation into how coagulation-related gene signatures can predict ESCC prognosis and immunotherapy responsiveness.\"},{\"question\":\"How was the CRGs signature developed and validated?\",\"answer\":\"Patients were stratified using consensus clustering, differential and univariate Cox analyses were applied to construct the signature, and multiple RNA transcriptome cohorts were used for validation.\"},{\"question\":\"What key findings link the signature to tumor immunity and immunotherapy response?\",\"answer\":\"High-risk ESCC showed higher immune infiltration, lower tumor mutation burden (TMB), higher TIDE, and a lower proportion of immunotherapy response compared with low-risk cases.\"}]","Multi-cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma - Research Article | PDF",1790191089,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b6b497920c319ae2d0253536a019021.webp",983,1389,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26192e1f8d2ef855d98b9196bc709e11.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ada62fb5fa81caf5a29b2b9238caad2.webp",981,1386,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f34c2edda93131fd7be738adef23596f.webp",980,1385]